Anticoagulant therapy is important for stroke prevention in people with atrial fibrillation, but a new study shows many people don’t stick with it.

For Afib patients, lowering the risk of stroke is crucial. A late-breaking trial presented at AHA Scientific Sessions compares anti-thrombotic agents when coronary disease is also a factor.